Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS professor receives international recognition for exceptional ethical values
2015-10-02

“You grow so fond of them,” Prof André Venter,
Head: Department of Paediatrics and Child Health,
says while doing his rounds with patients.
Prof Venter recently received the award for health professions
from the international organisation, Unashamedly Ethical.

“You are such a pretty baby,” Prof André Venter, Head: Department of Paediatrics and Child Health at the University of the Free State, whispers to a baby lying stretched out in her neonatal cradle.

He uses his fingertips to free her legs and arms carefully from the monitors and wires attached to her.

“See how much you have grown,” he says, tapping with his finger on her file. 1.2 kg - her weight indicates. 

In one of the other children’s wards, he joins a mother sitting with her sick baby. Speaking about the baby’s operation coming up within the next few months, he gives her an encouraging pat on the shoulder.

He visits yet another mother who is practising kangaroo care on her baby, and asks to hold the baby for a while.

“Gosh, you’re so nice and warm, let doctor hold you for a while,” he says, hugging the premature baby to his chest.

Prof Venter greets and thanks the nursing staff at the end of his ward rounds.

“Everything is not always good, but one can try to plan for the future from the challenges,” he says. “One should never concentrate on the immediate problem too much, but lift the morale of those using our services, those providing the services, and those who come here for training.”

It is this kind of passion and outlook that earned Prof Venter an ethical award from the international organisation, Unashamedly Ethical. The award, which was made in the health professions category, recognises doctors for exceptional ethical values and for going the extra mile in alleviating the suffering of humanity.

“I am humbled at being honoured for something I see as my passion and actually take for granted. I am also touched that people from outside noticed and nominated me for this,” he says.

He talks about his young patients again: “I learn so much from them each day. Children are so resistant to negative things. I grow so fond of them that I forget they have to go home some time.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept